Cargando…

Can we use hydroxychloroquine to treat COVID-19 now?

Detalles Bibliográficos
Autores principales:	Chen, Jun, Liu, Danping, Yin, Lin, Zhang, Lijun, Lu, Hongzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834540/ https://www.ncbi.nlm.nih.gov/pubmed/33408016 http://dx.doi.org/10.1016/j.ijantimicag.2020.106173

Ejemplares similares

Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis
por: Swarnakar, Raktim, et al.
Publicado: (2022)

Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis
por: Zeppieri, Marco
Publicado: (2023)

The looming pandemic of COVID-19: What therapeutic options do we have now?
por: Afsar, Nasir Ali
Publicado: (2020)

Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
por: Sun, Xiaoxuan, et al.
Publicado: (2020)

Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
por: Rani, Seema, et al.
Publicado: (2020)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs
por: Yu, Bo, et al.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

Interventions for Trauma-Related Nightmare: Where Are We Now?
por: Nie, Yuru, et al.
Publicado: (2023)

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2020)

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature
por: Goldman, Jason D., et al.
Publicado: (2021)

Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted
por: Barraud, Damien, et al.
Publicado: (2023)

Can Asia now learn from the experience of the West?
por: Tang, Julian W., et al.
Publicado: (2021)

Frailty as an Outcome Predictor After Ankle Fractures: Where Are We Now?
por: Mediouni, Mohamed, et al.
Publicado: (2018)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

COVID-19 and hydroxychloroquine: Let the available data speak for themselves
por: Paliani, Ugo, et al.
Publicado: (2020)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Comment on: Breast Implant Surfaces and Their Impact on Current Practices: Where Are We Now and Where Are We Going
por: Nava, Maurizio Bruno, et al.
Publicado: (2020)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Linschoten, Marijke, et al.
Publicado: (2021)

Update on hydroxychloroquine use in pregnancy
por: Nori, Wassan, et al.
Publicado: (2023)

The laryngectomee guide for COVID-19 is now available in Portuguese
por: Brook, Itzhak, et al.
Publicado: (2021)

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine
por: Verheijen, S., et al.
Publicado: (2021)

Hydroxychloroquine: is there a role in long COVID?
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Hydroxychloroquine and QT Prolongation in Older Patients with Rheumatic Diseases: Who is afraid of the Boogeyman? We are not!
por: Castagna, Alberto, et al.
Publicado: (2020)

Letter to the Editor: Acharya Prafulla Chandra Ray, Hydroxychloroquine and COVID-19
por: Gupta, Nikhil, et al.
Publicado: (2020)

Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
por: d’Arminio Monforte, Antonella, et al.
Publicado: (2020)

Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients
por: Brito-Azevedo, Anderson
Publicado: (2020)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19
por: Kavanagh, Oisín, et al.
Publicado: (2020)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9gusnggg5cbh7t36d2bgo7ia0b